ARTÍCULOS
Material de consulta
Hemos preparado una serie artículos descargables para que todos nuestros colegiados y médicos interesados los tengan como material de lectura. Te recomendamos revisar periódicamente esta sección para descargar nuevos contenidos.
WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition
© World Health Organization 2021
The Department of Sexual and Reproductive Health and Research and the Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes at the World Health Organization (WHO) would like to thank members of the Guideline Development Group (GDG) for their consistent availability and commitment to making this guideline possible, and the members of the External Review Group (ERG) and all other external contributors for their work.

European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncology (ESGO) joint considerations about human papillomavirus (HPV) vaccination, screening programs, colposcopy, and surgery during and after the COVID-19 pandemic
Accepted 21 May 2020 Published Online First 2 June 2020
The COVID-19 pandemic caused by SARS-CoV-2 has radically changed global healthcare. On May 13, 2020, all countries of the European Region reported their COVID-19 status, with 1 757 814 confirmed cases and 157 923 confirmed deaths.
European consensus statement on essential colposcopy
Received 14 April 2020 Received in revised form 24 May 2020 Accepted 15 June 2020
This European consensus statement on essential colposcopy provides standards for the general colposcopist seeing women referred for colposcopy with an abnormal cervical screening test (including cytology and HPV tests) or with a clinically suspicious cervix. The article gives guidance regarding the aims and conduct of colposcopy. Recommendations are provided on colposcopy technique, the management of common colposcopy issues, treatment and follow-up of after treatment of CIN or early stage cervical.

2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Key Words: cervical cytology, HPV testing, management of abnormal cervical cancer screening tests, guidelines (J Low Genit Tract Dis 2020;24: 102–131)
This is the fourth American Society of Colposcopy and Cervical Pathology (ASCCP)-sponsored consensus guidelines for management of cervical cancer screening abnormalities, after the original consensus conferences in 20011 and subsequent updates in 20062 and 2012.